GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » Gross Profit

Ovation Science (XCNQ:OVAT) Gross Profit : C$0.03 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ovation Science Gross Profit?

Ovation Science's gross profit for the three months ended in Mar. 2024 was C$0.02 Mil. Ovation Science's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.03 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Ovation Science's gross profit for the three months ended in Mar. 2024 was C$0.02 Mil. Ovation Science's Revenue for the three months ended in Mar. 2024 was C$0.04 Mil. Therefore, Ovation Science's Gross Margin % for the quarter that ended in Mar. 2024 was 50.00%.

Ovation Science had a gross margin of 50.00% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 7 years, the highest Gross Margin % of Ovation Science was 97.83%. The lowest was 55.74%. And the median was 86.26%.


Ovation Science Gross Profit Historical Data

The historical data trend for Ovation Science's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science Gross Profit Chart

Ovation Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial 0.28 0.55 0.19 0.14 0.05

Ovation Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 - - 0.01 0.02

Competitive Comparison of Ovation Science's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ovation Science's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Gross Profit distribution charts can be found below:

* The bar in red indicates where Ovation Science's Gross Profit falls into.



Ovation Science Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Ovation Science's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=0.062 - 0.008
=0.05

Ovation Science's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=0.04 - 0.02
=0.02

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.03 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Ovation Science's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.02 / 0.04
=50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Ovation Science  (XCNQ:OVAT) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ovation Science had a gross margin of 50.00% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Ovation Science Gross Profit Related Terms

Thank you for viewing the detailed overview of Ovation Science's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Ovation Science (XCNQ:OVAT) Business Description

Traded in Other Exchanges
Address
625 Howe Street, Suite 1140, Vancouver, BC, CAN, V6C 2T6
Ovation Science Inc is a Canada-based company mainly engaged in the business of sub-licensing rights to use Invisicare, a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products. The company also holds the right to manufacture, distribute, sell, market, sub-license and promote products formulated with Invisicare and containing cannabis products including cannabinoids, hemp seed oil and any synthetic derivatives of cannabis. It also develops formulas for skin product lines including topical and transdermal creams and lotions containing hemp seed oil and cannabis.
Executives
David K. Ryan Director

Ovation Science (XCNQ:OVAT) Headlines

No Headlines